Idorsia Ltd. · SIX:IDIA
Idorsia — Fact Sheet (July 2021)
6 slides from Idorsia's fact sheet, July 2021
Slide 1: Idorsia Company Profile
Idorsia Company Profile Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options. The
Slide 2: Share Information and Company Strategy
Share Information Company Strategy Idorsia was incorporated in March 2017 We will develop Idorsia into one of Europe’s Bring Idorsia to sustainable profitability and listed on the SIX Swiss Exchange (ticker leading biopharmaceutical companies, with We are building Idorsia with a long-term symbol: ID
Slide 3: Clinical Development Pipeline
Clinical Development Pipeline Compound Mechanism of Action Target Indication Status Daridorexant Dual orexin receptor antagonist Insomnia Under review with health authorities Aprocitentan* Dual endothelin receptor antagonist Resistant hypertension management Phase 3 recruitment complete Clazosentan
Slide 4: Partnerships
Partnerships Collaboration Agreement with Janssen Revenue Sharing Agreement with License agreement with Neurocrine Biotech, Inc. Johnson & Johnson In 2020, Idorsia entered into a global license In 2017, Idorsia entered into a collaboration In 2017, Idorsia and Actelion agreement with Neurocrine Bios
Slide 5: Company milestones
Company milestones 2021 2019 2018 June December June Initiation of Phase 3 registration study License Agreement with Mochida for the Initiation of Phase 3 registration study with with selatogrel for the treatment of acute supply, co-development and co-marketing of aprocitentan for resistant hyperten
Slide 6: About Idorsia, disclaimer and contact
Idorsia is an independent biopharmaceutical company based on science and innovation. The company is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. It is headquartered in Allschwil/Basel, Switzerland and is quoted on the SIX Swiss Exc